Universal Health Services (UHS)
NYSEHealth CareMedical Care FacilitiesSnapshot 2026-07-08
$156.35-3.04%
Close 2026-07-08 · 1-day change
Reading UHS? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track UHS free→NYSEHealth CareMedical Care FacilitiesSnapshot 2026-07-08
Reading UHS? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track UHS free→A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This is a multi-year thesis on a healthcare provider with a focus on maintaining revenue and earnings growth. The current state reflects a strong performance, but there are risks tied to sector dynamics and management execution.
The market currently prices UHS as cheap compared to its peers, reflecting a low expectations gap. However, there is a fragility due to weak execution quality, which could impact future performance.
Management has been on track with increasing revenue forecasts and maintaining earnings per share (EPS) growth. However, capital expenditure management is mixed, and there is a low probability of missing earnings expectations in the near term.
The thesis hinges on sector performance, particularly the results and guidance of major players like HCA, THC, and DVA. Positive momentum in the sector could support UHS, while negative trends could pose risks.
Overall, UHS is positioned well in terms of financial performance, but it must navigate sector risks and management challenges. Not investment advice.
The most important moves since the prior daily snapshot.
Mixed, the news cuts both ways. The latest earnings beat supports the read. However, a legal investigation may impact management's effectiveness and reputation.
as of 2026-07-08
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: If UHS keeps this growth rate, it will show it can keep making money.
Confirms:Q2 2026 EPS growth reported above 20% year over year.
Disproves:Q2 2026 EPS growth reported below 20% year over year.
Why it matters: If UHS grows faster, it will help its revenue. This shows strong performance.
Confirms:Q2 2026 revenue growth reported above 7% year over year.
Disproves:Q2 2026 revenue growth reported below 7% year over year.
Why it matters: Higher revenue would help UHS grow and meet management's revenue goals.
Confirms:Q2 net revenues exceed $4.5 billion.
Disproves:Q2 net revenues fall below $4.4 billion.
Why it matters: Changes in Medicaid may hurt UHS's revenue. It could also raise unpaid care.
Confirms:Good news on Medicaid funding or renewals can help stabilize revenue.
Disproves:Bad news on Medicaid funding or possible cuts can hurt.
Why it matters: An increase in revenue forecast would show strong growth momentum for UHS.
Confirms:Management raises the revenue forecast by more than 5% during the next earnings call.
Disproves:Management keeps the revenue forecast the same or lowers it.
Why it matters: Closing this deal would enhance UHS's outpatient and telehealth services. It could boost revenue and diversify payor mix.
Confirms:The acquisition will close in Q3 2026. All regulatory approvals are in place.
Disproves:The acquisition does not close. This is due to stockholder or regulatory problems.
Why it matters: Changes in Medicaid can greatly affect UHS's revenue and how it operates.
Confirms:Medicaid funding stays stable with no big cuts or changes.
Disproves:New laws may cut Medicaid funding or change who is eligible.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: Completing this purchase could help UHS's services. It may also boost its market position.
Confirms:A news release confirms the Talkspace purchase is complete.
Disproves:A news release says there are delays or problems with the purchase.
Why it matters: Good management of capital spending is key for UHS's financial health.
Confirms one read:Management says capital spending will drop by more than 10% in the next call.
Confirms the other:Management says capital spending will rise by more than 10%.